FILE PHOTO: Allergan CEO Brent Saunders gives an interview on the floor of the New York Stock Exchange (NYSE) April 6, 2016. REUTERS/Brendan McDermid/
FILE PHOTO: Allergan CEO Brent Saunders gives an interview on the floor of the New York Stock Exchange (NYSE) April 6, 2016. REUTERS/Brendan McDermid/